Amer Renal Assoc Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Amer Renal are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Amer Renal Assoc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Amer Renal is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Quick Ratio | 0.89 | |
| Fifty Two Week Low | 5.57 | |
| Target High Price | 11.50 | |
| Fifty Two Week High | 11.98 | |
| Target Low Price | 7.00 | |
| Trailing Annual Dividend Yield | 11.30% |
Amer |
Amer Renal Relative Risk vs. Return Landscape
If you would invest (100.00) in Amer Renal Assoc on September 14, 2024 and sell it today you would earn a total of 100.00 from holding Amer Renal Assoc or generate -100.0% return on investment over 90 days. Amer Renal Assoc is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Amer, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Amer Renal Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amer Renal's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amer Renal Assoc, and traders can use it to determine the average amount a Amer Renal's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ARA |
Based on monthly moving average Amer Renal is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amer Renal by adding Amer Renal to a well-diversified portfolio.
Amer Renal Fundamentals Growth
Amer Stock prices reflect investors' perceptions of the future prospects and financial health of Amer Renal, and Amer Renal fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amer Stock performance.
| Return On Equity | 17.51 | |||
| Return On Asset | 4.35 | |||
| Profit Margin | (1.11) % | |||
| Operating Margin | 9.73 % | |||
| Current Valuation | 1.26 B | |||
| Shares Outstanding | 34.54 M | |||
| Price To Earning | 144.04 X | |||
| Price To Book | (20.05) X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 814.1 M | |||
| EBITDA | 113.52 M | |||
| Cash And Equivalents | 126.9 M | |||
| Cash Per Share | 3.68 X | |||
| Total Debt | 724.51 M | |||
| Debt To Equity | 3.94 % | |||
| Book Value Per Share | (2.33) X | |||
| Cash Flow From Operations | 174.15 M | |||
| Earnings Per Share | (0.52) X | |||
| Total Asset | 938.28 M | |||
| Retained Earnings | (192.31 M) | |||
| Current Asset | 193.75 M | |||
| Current Liabilities | 97.47 M |
Things to note about Amer Renal Assoc performance evaluation
Checking the ongoing alerts about Amer Renal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amer Renal Assoc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amer Renal Assoc is not yet fully synchronised with the market data | |
| Amer Renal Assoc has some characteristics of a very speculative penny stock | |
| Amer Renal Assoc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 814.1 M. Reported Net Loss for the year was (16.86 M) with profit before taxes, overhead, and interest of 254.5 M. | |
| Over 81.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Amer Renal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amer Renal's stock is overvalued or undervalued compared to its peers.
- Examining Amer Renal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amer Renal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amer Renal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amer Renal's stock. These opinions can provide insight into Amer Renal's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Amer Stock
If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |